Just to show that market misrepresentation , this time in

New Post Public Reply Private Reply Replies (2) Message Board
someconcerns AlanC #38920
373
Just to show that market misrepresentation , this time in commodities, is not just by little guys:


RELEASE: pr7640-17

November 6, 2017
CFTC Orders Cargill, Inc. to Pay a $10 Million Civil Monetary Penalty for Providing Inaccurate Mid-Market Marks on Swaps, Which Concealed Cargill’s Full Mark-up, in Violation of Swap Dealer Business Conduct and Reporting Requirements, and for Failing to Supervise Swap Dealer Employees

Washington, DC – The Commodity Futures Trading Commission (CFTC) today announced the filing and simultaneous settlement of charges against Cargill, Inc. (Cargill), of Minnesota, for providing mid-market marks (marks) that concealed from counterparties and its swap data repository (SDR) its full mark-up on certain swaps, in violation of the Commodity Exchange Act (CEA) and Commission Regulations.

Specifically, the CFTC Order finds that Cargill provided counterparties and the SDR inaccurate marks which had the effect of concealing up to ninety percent of Cargill’s mark-up. Cargill also failed to diligently supervise its employees in connection with these inaccurate marks, and in connection with inaccurate statements made to swap counterparties. In particular, the CFTC Order finds that Cargill provided marks that concealed its full mark-up because of a concern that providing accurate marks would reduce Cargill’s revenue.

The CFTC Order requires Cargill to pay a $10 million civil monetary penalty, cease and desist from violating Section 4s(h)(1) of the CEA and Commission Regulations 23.431(a) and (d), 45.4(d)(2), and 166.3, as charged, and comply with certain remedial undertakings.

CFTC Enforcement Director Comments

CFTC Director of Enforcement James McDonald said: “The Commission will vigorously pursue those who undermine the fairness and integrity of our markets, as Cargill did by providing marks that concealed its full mark-up on the swaps at issue in this case. As the Order finds, Cargill provided its counterparties and SDR inaccurate information about its swaps, and did so because of a concern that disclosing its full markup—as it was required to do—could reduce its revenue. Participants in our markets are entitled to trust that information they receive from counterparties complies with governing laws and regulations. Thanks to the hard work of the team in this case, we uncovered the misconduct and brought this action to ensure the marks on the swaps will be accurate going forward.”

The CFTC Order finds that from 2013 to the present Cargill, a provisionally registered swap dealer, provided hundreds of counterparties and its SDR with mid-market marks on thousands of complex swaps that failed to comply with the CEA and Commission Regulations. Specifically, Cargill chose to provide counterparties a mid-market mark that failed to disclose Cargill’s full mark-up, as it was required to do. Instead, Cargill provided a mid-market mark that recognized only ten percent of its mark-up on the first day of the swap and amortized the remaining mark-up equally over the next sixty days. The result was that Cargill provided mid-market marks to counterparties that concealed up to ninety percent of Cargill’s mark-up.

The CFTC Order further finds that Cargill used this non-compliant mark methodology because of its concern that providing counterparties marks that disclosed Cargill’s full mark-up would reduce Cargill’s earnings. The CFTC Order also finds that Cargill undertook this course of conduct despite concerns within Cargill that this mark methodology did not comply with the requirements of the CEA and Commission Regulations. And the CFTC Order finds that Cargill deliberately avoided raising questions about the mid-market mark with the Commission to avoid “tip[ing Cargill’s] hand.”

Additionally, the CFTC Order finds that for certain swaps executed based on prices derived by Cargill’s ProPricing grain marketing program, Cargill on occasion inaccurately reported certain information to swap counterparties. Specifically, Cargill would disclose to swap counterparties the percentage that accounts for particular enrolled commodities were hedged. On a number of occasions since Cargill provisionally registered as a swap dealer in 2013, the accounts for particular commodities were over 100% hedged (i.e., short more than the amount of the particular enrolled commodity for that account) or less than zero percent hedged (i.e., long the particular enrolled commodity). In those instances, rather than reporting to counterparties the actual percent the accounts were hedged, Cargill employees would inaccurately report to swap counterparties that the account was exactly 100% hedged or exactly zero percent hedged, respectively. Despite the occurrence of these inaccurate communications since 2013, Cargill failed to develop systems or procedures to prevent inaccurate communications with swap counterparties.

Finally, the CFTC Order also finds that Cargill failed to diligently supervise its officers, employees, and agents relating to its business as a swap dealer. Among other failures, Cargill had no systems or procedures in place that could have prevented or corrected its inaccurate communications about ProPricing-related swaps with counterparties. Moreover, although Cargill employees were aware that Cargill’s mid-market marks for complex swaps did not reveal Cargill’s full mark-up, Cargill took no steps to bring its marks into compliance before they were provided to counterparties or the SDR.

The CFTC’s Enforcement Division thanks the French L’Autorité des marchés financiers (AMF) for its cooperation.

The CFTC Division of Enforcement staff members responsible for this case are Gabriella Geanuleas, Trevor Kokal, John Buffington, Candice Aloisi, and Manal Sultan.

Media Contact
Dennis Holden
202-418-5088

Last Updated: November 6, 2017

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Local Visibility Crisis Looms for Small Businesses

Updated Category News Views 3

Scrolling through these fresh stats from BrightLocal's recent report, you can almost hear the alarm bells echoing across small towns and city squares. The data paints a surprisingly sobering picture: despite the fact that 71% of folks are heading straight to Google to find local businesses, only a mere 22% of small business owners are tagging it as one of their top tools...

Continue Reading
Casio Unveils Analog G-SHOCKs with Iconic Style

Updated Category News Views 9

Blending the Old with the New Here's an interesting tidbit for all you watch aficionados and investors: Casio is set to drop the GMC-2500 and GAC-2500, a new wave of G-SHOCK watches that are marrying that vintage cool with today's swagger. Straight out of Tokyo, these timepieces are taking a page from the 1983 DW-5000C playbook, but the twist? They're going analog. It's a...

Continue Reading
Equity Alerts: Unraveling the Latest M&A Surprises

Updated Category News Views 6

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Continue Reading
Rznomics Advances with EU Orphan Status for RZ-001

Updated Category News Views 3

RZ-001's European Success: A New Frontier Look, when a biopharmaceutical firm's RNA-editing therapy snags an Orphan Medicinal Product Designation from the European Commission, it's not just some clipboard milestone—it's a heavy-hitter move. That's exactly what Rznomics, the South Korean gene therapy player, pulled off with RZ-001. Now, we aren't just seeing paperwork...

Continue Reading
American Lung Association's Push for Biomarker Testing

Updated Category News Views 4

Lung Cancer's Unseen Struggles and a Ray of Hope Not every day we get a chance to chew on the news of another initiative by the American Lung Association. They're ringing the bell again this year, focusing on the underutilized biomarker testing that could be the ticket to a longer life for lung cancer patients. When you dive into the stark figures, it hits hard. More than...

Continue Reading
Labcorp Scoops Up BioReference Health For $722M+

Updated Category News Views 8

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Continue Reading
Bambu Lab Shakes Up 3D Printing with Massive Discounts

Updated Category News Views 4

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...

Continue Reading
Highlight's Pulse Offers Real-Time Consumer Insights

Updated Category News Views 6

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...

Continue Reading
Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 5

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading
Country Stars Illuminate Art in Philly, Mississippi

Updated Category News Views 0

A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...

Continue Reading

Top 5 Most Recently Viewed Articles

Thumzup Media Celebrates Nasdaq Listing with New Offerings

Updated Category News Views 64

Thumzup Media Corporation Announces Its Nasdaq Listing Thumzup Media Corporation, known for revolutionizing social media branding, has recently made a significant move by listing its shares on Nasdaq. This exciting development allows Thumzup (OTCQB: TZUP) to broaden its reach and enhance its visibility in the competitive landscape of digital marketing. The company's...

Continue Reading
Lumene Group Transforms Cyber Safety for Brand Protection

Updated Category News Views 166

Lumene Group Transforms Cyber Safety for Brand Protection Lumene Group has made significant advancements in its cybersecurity services in collaboration with Elisa. This innovative partnership focuses on protecting the company's brand integrity while actively monitoring for potential counterfeits. The updated cyber solutions include round-the-clock vigilance against cyber...

Continue Reading
J.B. Hunt's Stock Target Upgraded Amid Market Challenges

Updated Category News Views 266

J.B. Hunt Stock Target Upgraded Recently, Bernstein SocGen Group made an important adjustment to its stock price target for J.B. Hunt Transport Services (NASDAQ: JBHT). The new target is set at $184.00, just slightly higher than the previous figure of $182.00. Despite this modest increase, the firm maintains a Market Perform rating on the company's stock. Market Analysis...

Continue Reading
Home Helpers Home Care Recognized as Top Franchise for Profitability

Updated Category News Views 196

Home Helpers Home Care Achieves Prestigious Franchise Recognition Brand stands out among 75 franchises based on extensive research of over 35,000 franchise owners Home Helpers Home Care, a national leader in non-medical, in-home companionship and personal care services, has been honored with the title of one of the 2025 Most Profitable Franchises as recognized by...

Continue Reading
CSL's ANDEMBRY® Receives Health Canada Approval for HAE Care

Updated Category News Views 106

CSL's ANDEMBRY® Gains Approval in Canada Health Canada has officially approved ANDEMBRY® (garadacimab) as the first and only once-monthly treatment for hereditary angioedema (HAE). This crucial advancement marks a significant step forward for individuals grappling with HAE, a rare genetic condition that can lead to severe and unpredictable swelling attacks. A New Era...

Continue Reading